New vaccine aimed at training immune system to fight advanced breast cancer enters first human tests
⭐️ VACCINE ⭐️
Recruiting now
This early-stage trial tests a new vaccine called ES2B-C001, with or without an immune booster (adjuvant), in 40 people with HER2-positive metastatic breast cancer who have already tried other treatments. The vaccine is designed to help the body's immune system recognize and atta…
Phase: PHASE1 • Sponsor: ExpreS2ion Biotechnologies • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:06 UTC